Altach Biomedical, an Irish health tech startup led by Tomir Kosowski, has raised €1.2 million in a seed round of funding. The investment was backed by NLC Health Ventures’ Stepping Stone Fund, Castanjo B.V., and joined by angel investors.
- Altach Biomedical was co-founded in 2022, by Tomir Kosowski, Danny Kelly, and David Browe, as a spin-out of Trinity College Dublin. It develops a novel biomimetic (the imitation of biological processes from nature) scaffold made from collagen, which aid in the regeneration of cartilage. According to Altach, it aims to improve treatment outcomes for patients with cartilage damage, reducing the need for invasive surgeries.
Our technology marks a significant advancement in how we treat articular cartilage injuries. Our scaffolds could reduce recovery times and increase the quality of healing, profoundly improving patients’ daily lives,
Tomir Kosowski, CEO and co-founder at Altach, said.
- The €1.2 million funding round was backed by several prominent investors, including NLC Health Ventures, an Amsterdam-based health tech venture builder, Stepping Stone Fund, Castanjo BV, a crowdfunding campaign on an Irish Spark Crowdfunding, and two unnamed angel investors.
Founder and co-inventor Prof. Danny Kelly
We have already met several key development milestones including the recent granting of our US patent; however this funding will now allow us to scale up manufacturing and validate our product in advance of clinical use,
Prof. David Browe, CTO and co-founder at Altach Biomedical, commented.
Altach Biomedical will spend the fresh investment to continue its development and bring the technology for the treatment of cartilage defects to the hands of surgeons in the near future.
